机译:雌二醇和黄体酮的改变的雌二醇和孕酮与骨髓衍生的抑制细胞和早期流产的Th1 / Th2细胞因子有关母体胎儿耐受性的早期分解相关
Department of Molecular &
Human GeneticsBanaras Hindu UniversityVaranasi India;
Department of Molecular &
Human GeneticsBanaras Hindu UniversityVaranasi India;
Department of Molecular &
Human GeneticsWeizmann Institute of ScienceRehovot Israel;
Department of Molecular &
Human GeneticsBanaras Hindu UniversityVaranasi India;
Department of Obstetrics &
Gynecology Institute of Medical SciencesBanaras Hindu;
Department of Obstetrics &
Gynecology Institute of Medical SciencesBanaras Hindu;
Department of Obstetrics &
Gynecology Institute of Medical SciencesBanaras Hindu;
Department of Obstetrics &
Gynecology Institute of Medical SciencesBanaras Hindu;
Division of EndocrinologyCSIR‐CDRILucknow India;
Department of Molecular &
Human GeneticsBanaras Hindu UniversityVaranasi India;
early miscarriage; estradiol; myeloid‐derived suppressor cells; successful pregnancy; Th1/Th2 immunity;
机译:雌二醇和黄体酮的改变的雌二醇和孕酮与骨髓衍生的抑制细胞和早期流产的Th1 / Th2细胞因子有关母体胎儿耐受性的早期分解相关
机译:Frontline Science:骨髓衍生的抑制细胞(MDSCs)促进小鼠的母体胎儿耐受性
机译:HLA-G在肿瘤衍生中的作用是通过髓样来源的抑制性细胞的扩增和细胞因子平衡,有利于Th2和Th1 / Th17。
机译:用Janus合成纳米颗粒抗体耗尽骨髓来源的抑制细胞作为癌症免疫治疗。
机译:使用Multiplex IHC鉴定NSCLC中识别骨髓衍生的抑制细胞和抗原呈递细胞
机译:患有大型和局部晚期乳腺癌的女性T调节细胞异常(Tregs:FOXP3 +CTLA-4 +)髓样来源的抑制细胞(MDSCs:单核细胞粒细胞)和极化的T辅助细胞谱(Th1Th2Th17)新辅助化疗(NAC)和手术:治疗无效的treg谱废除失败以及treg水平与NAC病理反应的相关性
机译:患有大型和局部晚期乳腺癌的女性,T调节细胞异常(Tregs:FOXP3 +,CTLA-4 +),髓样来源的抑制细胞(MDSCs:单核细胞,粒细胞)和极化的T辅助细胞特征(Th1,Th2,Th17)新辅助化疗(NAC)和手术:治疗无效treg谱的消除失败以及treg水平与NAC病理反应的相关性
机译:流式细胞术快速常规检测全血外周血T细胞TH1 / TH2细胞因子平衡